Biofrontera AG:Ad hoc: Biofrontera AG lists New Shares at the regulated stock market

Biofrontera AG / / Ad hoc: Biofrontera AG lists New Shares at the regulated stock market . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Leverkusen, Germany 02 May 2012 - In March 2012 Biofrontera AG has issued 4,402,682 new shares (New Shares), which were included into the company's registry on 30 March 2012. In the offer of the New Shares to existing shareholders and elsewhere it was announced that the New Shares will be introduced into the regulated stock market within the legal period, i.e. within one year. Since a financial service company has in the meantime - without involvement of the company - listed the New Shares in the open market of the Düsseldorf stock exchange on April 11, 2012, Biofrontera recognizes the need to introduce the New Shares into the regulated market immediately, in contrast to the original intention. The separate listing of Biofrontera shares in the open market (DE000A1MMD83) has opened the possibility of unjustified arbitrage deals, may have caused irritation with share holders and contributed to  a negative stock price development. Today, the management of Biofrontera AG has therefore decided to apply for the listing of the New Shares in the regulated market, such that trading under the ISIN DE0006046113 can commence immediately following the company's ordinary share holder meeting, taking place on 11 May 2012. The listing will not affect the contractual 2-year lock-up that was agreed upon with an investor for 2,017,896 New Shares (compare ad-hoc releases of March 2 and 23, 2012). Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen ISIN: DE0006046113 WKN: 604611 Contact: Werner Pehlemann Biofrontera AG Tel.: +49 (0214) 87 63 20, Fax.: +49 (0214) 87 63 290 E-mail: This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Biofrontera AG via Thomson Reuters ONE [HUG#1607864]